Toggle light / dark theme

Intel to Release Neuromorphic-Computing System

Intel Corp. is releasing an experimental research system for neuromorphic computing, a cutting-edge method that simulates the way human brains work to perform computations faster, using significantly less energy.

The system, called Pohoiki Springs, will be made available this month over the cloud to members of the Intel Neuromorphic Research Community, which includes academic researchers, government labs and about a dozen companies such as Accenture PLC and Airbus SE.

Others, including International Business Machines Corp., are also researching the technique.

Scents alter how memories are processed in the brain, new study suggests

Have you ever gotten a whiff of a certain smell that brought you back to childhood? Or maybe a scent that reminded you of a past love affair?

A paper published in Learning and Memory reveals the power scents have to trigger memories of past experiences, as well as the possibility for odor to be used in treating memory-related disorders.

“If odor could be used to elicit the rich recollection of a memory — even of a traumatic experience — we could take advantage of that [therapeutically],” said Boston University neuroscientist Steve Ramirez, assistant professor of psychology and brain sciences and senior author of the study, in a statement.

Switch Hypothesis (1) – A theory of how AI & brain recognize things

A theory of how #AI & #brain recognize things. https://bit.ly/2Qnq3RC “In this article, we proposed a hypothesis that we call Switch Hypothesis for explaining how an ANN as well as a real neural network carry out its functions…” #MachineLearning #DeepLearning #NeuralNetworks


Neuroscience and psychology today has advanced significantly. With the use of neuroimaging methods such as functional magnetic resonance imaging (fMRI) and electroencephalography (EEG), human beings have gradually revealed the secrets behind how our brains perceive, recognize and memorize things. However, if you’d like to have a detailed, neuronal-level elucidation on how brains realize its functions, you should be very disappointed because no one is currently capable of doing so. In other words, although our cerebrums are no longer a pitch-black box, it’s still at least a “gray” box, with a lot of enigmas yet to be explained.

New scanner can improve the detection of cancer tissue and brain disease diagnoses

A group of neuroscience and neurotechnology researchers have conducted extensive research and developed a new brain imaging technology in two EU projects led by Aalto University. As a result of the successful research, a new project funded by Business Finland just started with the aim of making the devices usable for patients. The project’s budget is one million euros.

“More can be helpful in locating epileptic activity before surgery. The new device is also expected to help distinguish brain tumours from healthy tissue more accurately prior to cancer surgery. In addition, the device will increase our understanding of the connections between the different brain regions. This will help us understand abnormal brain activity in connection with, for example, depression or the progress of Alzheimer’s disease,” explains Professor Risto Ilmoniemi, Head of Aalto University Department of Neuroscience and Biomedical Engineering.

The improved accuracy can also be useful in the study of stroke, autism and brain injuries; and especially as part of basic brain research.

Brain-doping produced by your own body

Erythropoietin, or Epo for short, is a notorious doping agent. It promotes the formation of red blood cells, leading thereby to enhanced physical performance — at least, that is what we have believed until now. However, as a growth factor, it also protects and regenerates nerve cells in the brain. Researchers at the Max Planck Institute of Experimental Medicine in Göttingen have now revealed how Epo achieves this effect. They have discovered that cognitive challenges trigger a slight oxygen deficit (termed ‘functional hypoxia’ by the researchers) in the brain’s nerve cells. This increases production of Epo and its receptors in the active nerve cells, stimulating neighbouring precursor cells to form new nerve cells and causing the nerve cells to connect to one another more effectively.

The growth factor erythropoietin is among others responsible for stimulating the production of red blood cells. In anaemia patients it promotes blood formation. It is also a highly potent substance used for illegal performance enhancement in sports.

“Administering Epo improves regeneration after a stroke (termed ‘neuroprotection’ or ‘neurogeneration’), reducing damage in the brain. Patients with mental health disorders such as schizophrenia, depression, bipolar disorder or multiple sclerosis who have been treated with Epo have shown a significant improvement in cognitive performance,” says Hannelore Ehrenreich of the Max Planck Institute of Experimental Medicine. Along with her colleagues, she has spent many years researching the role played by Epo in the brain.

Battelle-Led Team Wins DARPA Award to Develop Injectable, Bi-Directional Brain Computer Interface

Here’s an exciting concept that was actually first discussed in 1959 by Richard Feynman in an article entitled “There’s Plenty of Room at the Bottom”.

I am most interested in this technology for mind uploading.

“Battelle’s N3 concept for a minimally invasive neural interface system, called BrainSTORMS (Brain System to Transmit Or Receive Magnetoelectric Signals), involves the development of a novel nanotransducer that could be temporarily introduced into the body via injection and then directed to a specific area of the brain to help complete a task through communication with a helmet-based transceiver.”


COLUMBUS, Ohio—()—Battelle has for years successfully demonstrated brain-computer interface (BCI) projects—just look at NeuroLife®, which has enabled a quadriplegic man to move his hand again using his thoughts. Now, the government’s forward-thinking Defense Advanced Research Projects Agency (DARPA) has awarded a contract to a Battelle-led team that pushes researchers into the realm of what was once considered science fiction.

“This is one of the most exciting and challenging projects I have worked on” Tweet this

Imagine this: A soldier puts on a helmet and uses his or her thoughts alone to control multiple unmanned vehicles or a bomb disposal robot. That’s the basis for this effort for DARPA’s Next-Generation Non-Surgical Neurotechnology (N3) program. The N3 program seeks development of high-performance, bi-directional brain-machine interfaces for able-bodied service members. Most of the current BCI research, including Battelle’s NeuroLife technology, focuses on helping people with disabilities who must undergo invasive implant procedures, including brain surgery, to enable a BCI that can restore lost function. For the next BCI leap, in which the technology can be used by healthy military service members, it’s imperative to find lower-risk and less-invasive options.

Scientists find toolkit to aid repair of damaged DNA

March 9 (UPI) — Scientists have developed a technique for repairing damaged DNA. The breakthrough, published this week in the journal Nature Communications, could pave the way for new therapies for cancer and neurodegenerative disorders.

The accumulation of DNA damage is responsible for aging, cancer and neurological diseases like motor neuron disease, also known as ALS.

Until now, scientists have struggled to find ways to repair this kind of damage. However, researchers have discovered a new protein called TEX264 that can combine with other enzymes to find and destroy toxic proteins that bind to DNA and trigger damage.

/* */